Stock Track | ANGELALIGN Soars 5.40% Intraday on MDR-CE Certification for EU Market Access

Stock Track01-08

ANGELALIGN (06699) surged 5.40% during Thursday's intraday session, reflecting strong investor optimism following the company's recent regulatory milestone.

The clear aligner specialist obtained the MDR-CE certificate from TÜV SÜD, confirming its products meet the EU's stringent Medical Device Regulation requirements. This certification marks a critical step in ANGELALIGN's international expansion, as it enables access to high-standard European markets and enhances the company's global credibility.

CEO Hu Jiezhang highlighted that international cases now represent over 50% of total case volume, with operations spanning 60+ countries. The MDR-CE certification is expected to further strengthen ANGELALIGN's competitive position in the global clear aligner market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment